vs
Avidbank Holdings, Inc.（AVBH）与ROCKWELL MEDICAL, INC.（RMTI）财务数据对比。点击上方公司名可切换其他公司
Avidbank Holdings, Inc.的季度营收约是ROCKWELL MEDICAL, INC.的1.5倍（$28.0M vs $18.3M），Avidbank Holdings, Inc.净利率更高（32.3% vs -3.0%，领先35.3%）
Avidbank Holdings, Inc.是一家总部位于美国的金融控股公司，通过旗下子公司AvidBank运营，主要为加利福尼亚州的中小企业、企业主和高净值人群提供商业银行产品与服务，涵盖商业贷款、存款账户、现金管理及定制化融资方案，覆盖制造、科技、房地产等多个行业领域。
罗克韦尔医疗成立于1996年，总部位于美国密歇根州威克瑟姆，是一家上市制药企业，核心业务聚焦于终末期肾病与慢性肾病相关治疗方案的研发与商业化推广。
AVBH vs RMTI — 直观对比
营收规模更大
AVBH
是对方的1.5倍
$18.3M
净利率更高
AVBH
高出35.3%
-3.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $28.0M | $18.3M |
| 净利润 | $9.0M | $-554.0K |
| 毛利率 | — | 21.1% |
| 营业利润率 | — | -2.2% |
| 净利率 | 32.3% | -3.0% |
| 营收同比 | — | -25.6% |
| 净利润同比 | 65.9% | 26.7% |
| 每股收益（稀释后） | $0.84 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVBHRMTI
| Q1 26 | $28.0M | — | ||
| Q4 25 | $26.8M | $18.3M | ||
| Q3 25 | $48.0K | $15.9M | ||
| Q2 25 | $21.8M | $16.1M | ||
| Q1 25 | — | $18.9M | ||
| Q4 24 | — | $24.7M | ||
| Q3 24 | — | $28.3M | ||
| Q2 24 | — | $25.8M |
净利润AVBHRMTI
| Q1 26 | $9.0M | — | ||
| Q4 25 | $6.9M | $-554.0K | ||
| Q3 25 | $-37.7M | $-1.8M | ||
| Q2 25 | $5.8M | $-1.5M | ||
| Q1 25 | — | $-1.5M | ||
| Q4 24 | — | $-756.0K | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $343.0K |
毛利率AVBHRMTI
| Q1 26 | — | — | ||
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% |
营业利润率AVBHRMTI
| Q1 26 | — | — | ||
| Q4 25 | — | -2.2% | ||
| Q3 25 | -110491.7% | -9.9% | ||
| Q2 25 | 38.0% | -8.4% | ||
| Q1 25 | — | -7.2% | ||
| Q4 24 | — | -2.1% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 2.0% |
净利率AVBHRMTI
| Q1 26 | 32.3% | — | ||
| Q4 25 | 25.9% | -3.0% | ||
| Q3 25 | -78614.6% | -11.0% | ||
| Q2 25 | 26.6% | -9.3% | ||
| Q1 25 | — | -8.0% | ||
| Q4 24 | — | -3.1% | ||
| Q3 24 | — | 5.9% | ||
| Q2 24 | — | 1.3% |
每股收益（稀释后）AVBHRMTI
| Q1 26 | $0.84 | — | ||
| Q4 25 | $0.65 | $-0.01 | ||
| Q3 25 | $-4.12 | $-0.05 | ||
| Q2 25 | $0.75 | $-0.05 | ||
| Q1 25 | — | $-0.04 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | — | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $10.7M |
| 总债务越低越好 | $55.0M | — |
| 股东权益账面价值 | $287.2M | $37.0M |
| 总资产 | $2.5B | $57.1M |
| 负债/权益比越低杠杆越低 | 0.19× | — |
8季度趋势，按日历期对齐
现金及短期投资AVBHRMTI
| Q1 26 | — | — | ||
| Q4 25 | — | $10.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $12.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $15.7M | ||
| Q3 24 | — | $12.3M | ||
| Q2 24 | — | $11.9M |
总债务AVBHRMTI
| Q1 26 | $55.0M | — | ||
| Q4 25 | $60.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益AVBHRMTI
| Q1 26 | $287.2M | — | ||
| Q4 25 | $278.4M | $37.0M | ||
| Q3 25 | $273.1M | $37.0M | ||
| Q2 25 | $204.4M | $30.4M | ||
| Q1 25 | — | $31.5M | ||
| Q4 24 | — | $32.6M | ||
| Q3 24 | — | $29.1M | ||
| Q2 24 | — | $23.5M |
总资产AVBHRMTI
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $57.1M | ||
| Q3 25 | $2.4B | $57.5M | ||
| Q2 25 | $2.4B | $52.6M | ||
| Q1 25 | — | $54.0M | ||
| Q4 24 | — | $59.2M | ||
| Q3 24 | — | $57.1M | ||
| Q2 24 | — | $53.0M |
负债/权益比AVBHRMTI
| Q1 26 | 0.19× | — | ||
| Q4 25 | 0.22× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $2.3M |
| 自由现金流经营现金流 - 资本支出 | — | $2.2M |
| 自由现金流率自由现金流/营收 | — | 12.0% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.2M |
8季度趋势，按日历期对齐
经营现金流AVBHRMTI
| Q1 26 | — | — | ||
| Q4 25 | — | $2.3M | ||
| Q3 25 | $12.4M | $-1.3M | ||
| Q2 25 | $10.7M | $1.8M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $865.0K | ||
| Q3 24 | — | $4.3M | ||
| Q2 24 | — | $1.4M |
自由现金流AVBHRMTI
| Q1 26 | — | — | ||
| Q4 25 | — | $2.2M | ||
| Q3 25 | $12.4M | $-1.5M | ||
| Q2 25 | $10.6M | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M |
自由现金流率AVBHRMTI
| Q1 26 | — | — | ||
| Q4 25 | — | 12.0% | ||
| Q3 25 | 25783.3% | -9.6% | ||
| Q2 25 | 48.6% | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% |
资本支出强度AVBHRMTI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.5% | ||
| Q3 25 | 72.9% | 1.4% | ||
| Q2 25 | 0.3% | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% |
现金转化率AVBHRMTI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.84× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVBH
| Net Interest Income | $26.5M | 95% |
| Noninterest Income | $1.5M | 5% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
